A hot topic with suboxone at the moment

Not sure how Adapax (benzhydrocodone and acetaminophen) from Kempharm differentiates itself – especially as still ‘high potential for abuse’

Its just a combination of a couple of old drugs and ‘KemPharm hoping to differentiate its product once it hits the market’ sounds vague

But basically its $150m a month – even with parity pricing with generics at 20-30 cents per pill and only a 20% capture of the market – NOT BAD